231 related articles for article (PubMed ID: 11530281)
1. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
Yoon K; Pallaroni L; Stoner M; Gaido K; Safe S
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):25-32. PubMed ID: 11530281
[TBL] [Abstract][Full Text] [Related]
2. Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines.
Yoon K; Pellaroni L; Ramamoorthy K; Gaido K; Safe S
Mol Cell Endocrinol; 2000 Apr; 162(1-2):211-20. PubMed ID: 10854714
[TBL] [Abstract][Full Text] [Related]
3. Toxicology of environmental estrogens.
Safe SH; Pallaroni L; Yoon K; Gaido K; Ross S; Saville B; McDonnellc D
Reprod Fertil Dev; 2001; 13(4):307-15. PubMed ID: 11800169
[TBL] [Abstract][Full Text] [Related]
4. Problems for risk assessment of endocrine-active estrogenic compounds.
Safe SH; Pallaroni L; Yoon K; Gaido K; Ross S; McDonnell D
Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):925-9. PubMed ID: 12634121
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
Wu F; Safe S
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
[TBL] [Abstract][Full Text] [Related]
6. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521
[TBL] [Abstract][Full Text] [Related]
7. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
[TBL] [Abstract][Full Text] [Related]
8. Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds.
Li X; Zhang S; Safe S
J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):122-32. PubMed ID: 16413991
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
Levenson AS; Catherino WH; Jordan VC
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):261-8. PubMed ID: 9219916
[TBL] [Abstract][Full Text] [Related]
10. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.
Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS
In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835
[TBL] [Abstract][Full Text] [Related]
11. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
13. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha.
Klotz DM; Hewitt SC; Korach KS; Diaugustine RP
Endocrinology; 2000 Sep; 141(9):3430-9. PubMed ID: 10965916
[TBL] [Abstract][Full Text] [Related]
14. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol.
Gould JC; Leonard LS; Maness SC; Wagner BL; Conner K; Zacharewski T; Safe S; McDonnell DP; Gaido KW
Mol Cell Endocrinol; 1998 Jul; 142(1-2):203-14. PubMed ID: 9783916
[TBL] [Abstract][Full Text] [Related]
15. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
17. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells.
Castro-Rivera E; Wormke M; Safe S
Mol Cell Endocrinol; 1999 Apr; 150(1-2):11-21. PubMed ID: 10411295
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
20. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
